Alpha Pro Tech (APT) Director Reports 5,615 RSU Grant on Amended Form 4

Rhea-AI Filing Summary

Dr. John Ritota, a director of Alpha Pro Tech Ltd (APT), reported an amended Form 4 correcting the filing date to October 1, 2025. The filing shows a grant of 5,615 time-based restricted stock units under the companys 2020 Omnibus Plan that vest in full on the first anniversary of the grant, with an acquisition price of $0. After the grant Dr. Ritota beneficially owns 48,355 shares. The form also discloses 5,000 shares held indirectly by his daughter and 7,000 shares held indirectly by his spouse, with Dr. Ritota disclaiming beneficial ownership of those indirect holdings.

Insights

Corporate Governance Expert

TL;DR: A routine director RSU grant was reported and the filing date was corrected; this is standard executive compensation reporting.

The amended Form 4 documents a time-based restricted stock unit award of 5,615 RSUs to a company director that vest in one year and carry no purchase price, consistent with equity-based compensation practices for non-employee directors or executive directors. The correction to the filing date appears administrative. The disclosure of indirect holdings by immediate family members with a disclaimer by Dr. Ritota is standard and clarifies his direct versus indirect ownership. Overall, the filing is procedural and does not indicate unusual governance actions.

Securities Analyst

TL;DR: The transaction increases reported insider alignment with shareholders but is not likely material to valuation.

The 5,615 RSU grant increases the directors direct reported stake to 48,355 shares; because the award vests after one year and was granted at $0, it represents standard retention or compensation rather than a cash investment. For most investors this size of grant is immaterial relative to a public companys market capitalization unless APT is very small. The amendment correcting the filing date improves regulatory accuracy but does not change the economics of the grant.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

RITOTA JOHN

(Last) (First) (Middle)

53 WELLINGTON STREET EAST

(Street)

AURORA A6 L4G 1H6

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALPHA PRO TECH LTD [ APT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
10/01/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/29/2025		A		5,615(1)	A	$0	48,355	D
Common Stock								5,000	I	by daughter, Dr. Ritota disclaims beneficial ownership
Common Stock								7,000	I	by spouse, Dr.Ritota disclaims beneficial ownership

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of time-based restricted stock units granted under the Alpha Pro Tech, Ltd. 2020 Omnibus Plan ( the "Plan") that will vest in full on the first anniversary of the grant date, subject to the terms of the Plan and the applicable award agreement.

Remarks:

this is to correct the filing date to October 1, 2025 to be todays filing date.

	/s/ Dr. John Ritota	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Dr. John Ritota report on the Form 4/A for APT?

He reported a grant of 5,615 time-based restricted stock units that vest in full on the first anniversary and updated the filing date to October 1, 2025.

How many APT shares does Dr. Ritota beneficially own after the reported transaction?

48,355 shares beneficially owned following the RSU grant.

Were there any indirect holdings disclosed on the Form 4/A for APT?

Yes: 5,000 shares held by his daughter and 7,000 shares held by his spouse, with Dr. Ritota disclaiming beneficial ownership of those shares.

What is the vesting schedule and cost for the RSUs granted to Dr. Ritota?

The 5,615 RSUs vest in full on the first anniversary of the grant date and were reported with an acquisition price of $0.

Does the amended Form 4/A indicate any sale or disposition by Dr. Ritota?

No disposals were reported; the filing records an acquisition of RSUs and lists existing direct and indirect holdings.